Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report. Issue 2 (10th January 2020)

Record Type:: Journal Article
Title:: Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report. Issue 2 (10th January 2020)
Main Title:: Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
Authors:: Beziat, Guillaume
Gauthier, Martin
Protin, Caroline
Oberic, Lucie
Lerebours, Fleur
Carlier, Jasmine
Ysebaert, Loïc
Abstract:: Abstract: Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia. Abstract : Venetoclax with high‐dose methotrexate and rituximab seem effective and safe to treat central nervous system involvement of chronic lymphocytic leukemia.
Is Part Of:: Clinical case reports. Volume 8:Issue 2(2020)
Journal:: Clinical case reports
Issue:: Volume 8:Issue 2(2020)
Issue Display:: Volume 8, Issue 2 (2020)
Year:: 2020
Volume:: 8
Issue:: 2
Issue Sort Value:: 2020-0008-0002-0000
Page Start:: 269
Page End:: 273
Publication Date:: 2020-01-10
Subjects:: central nervous system involvement -- chronic lymphocytic leukemia -- venetoclax
Medicine -- Periodicals
616.09
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904 ↗
DOI:: 10.1002/ccr3.2580 ↗
Languages:: English
ISSNs:: 2050-0904
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12928.xml